Almuradova E, Seyyar M, Arak H, Tamer F, et al. The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study. Int J Cancer 2023 Oct 11. doi: 10.1002/ijc.34749.
PMID: 37818966